Biohaven Ltd.
BHVN · NYSE · USD
$11.93
+0.05 0.42%todayNot financial advice.
- Open
- 11.83
- Day range
- 11.46 - 12.12
- 52-week range
- 7.48 - 18.57
- Volume
- 2.7M
- Market cap
- 1.8B
- P/E ratio
- —
- EPS
- -4.65
- Dividend yield
- 0.00%
- Beta
- 2.14
Performance
W
−10.37%
1M
−19.99%
3M
−27.03%
6M
+27.05%
YTD
+4.93%
Y
−21.15%
5Y
+98.83%
All
+98.83%
In the news
Oct 8
Biohaven Partners With Ono Pharmaceutical in 100 Million Dollar Asian Licensing Deal
Biohaven Ltd. partnered with Ono Pharmaceutical to license its autoimmune drug portfolio in Asia, securing up to 100 million dollars in near-term payments.
Company news
Oct 8
Biohaven Reaches Licensing Deal With Japan's Ono Pharmaceutical Valued Up to $100 Million
Biohaven partners with Japan's Ono Pharmaceutical to advance its MoDE drug pipeline in several Asian territories.
Company news
Oct 8
Biohaven Licenses IgG Degraders to Ono Pharma With BHV-1300 in Phase 3
Biohaven has partnered with Ono Pharma to license its IgG degraders in Japan and select Asian markets, expanding its immunology pipeline reach.
Company news
Embed on your site
Embed docsAdd a live price card or a chart to any page. Free, no sign-up; cards refresh every minute and link back here.
<iframe src="https://stocks.freetheai.org/embed/NYSE-BHVN" width="340" height="170" style="border:0;max-width:100%" loading="lazy" title="Biohaven Ltd. (BHVN) - FreeTheAI Stocks"></iframe>
<p style="font-size:12px"><a href="https://stocks.freetheai.org/symbols/NYSE-BHVN">BHVN stock price</a> by FreeTheAI Stocks</p>